These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27090790)

  • 1. Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus.
    Lorente E; Barriga A; Barnea E; Mir C; Gebe JA; Admon A; López D
    Mol Cell Proteomics; 2016 Jun; 15(6):2141-51. PubMed ID: 27090790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-DP peptide repertoire from human respiratory syncytial virus is focused on major structural proteins with the exception of the viral polymerase.
    Lorente E; Barnea E; Mir C; Admon A; López D
    J Proteomics; 2020 Jun; 221():103759. PubMed ID: 32244010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence.
    Lorente E; Barriga A; Barnea E; Palomo C; García-Arriaza J; Mir C; Esteban M; Admon A; López D
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007547. PubMed ID: 31276466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.
    Johnstone C; Lorente E; Barriga A; Barnea E; Infantes S; Lemonnier FA; David CS; Admon A; López D
    Mol Cell Proteomics; 2015 Apr; 14(4):893-904. PubMed ID: 25635267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.
    Infantes S; Lorente E; Barnea E; Beer I; Cragnolini JJ; García R; Lasala F; Jiménez M; Admon A; López D
    Mol Cell Proteomics; 2010 Jul; 9(7):1533-9. PubMed ID: 20081153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells.
    Lorente E; Martín-Galiano AJ; Barnea E; Barriga A; Palomo C; García-Arriaza J; Mir C; Lauzurica P; Esteban M; Admon A; López D
    J Proteome Res; 2019 Mar; 18(3):900-911. PubMed ID: 30629447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design.
    López D; Barriga A; Lorente E; Mir C
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30974886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.
    Kotelkin A; Belyakov IM; Yang L; Berzofsky JA; Collins PL; Bukreyev A
    J Virol; 2006 Jun; 80(12):5958-67. PubMed ID: 16731934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cell immunity against human respiratory syncytial virus.
    Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
    Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.
    Infantes S; Lorente E; Cragnolini JJ; Ramos M; García R; Jiménez M; Iborra S; Del Val M; López D
    Immunol Cell Biol; 2011 May; 89(4):558-65. PubMed ID: 20975736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.
    Chatterjee S; Luthra P; Esaulova E; Agapov E; Yen BC; Borek DM; Edwards MR; Mittal A; Jordan DS; Ramanan P; Moore ML; Pappu RV; Holtzman MJ; Artyomov MN; Basler CF; Amarasinghe GK; Leung DW
    Nat Microbiol; 2017 Jun; 2():17101. PubMed ID: 28665409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus nonstructural proteins 1 and 2 are crucial pathogenic factors that modulate interferon signaling and Treg cell distribution in mice.
    Yang P; Zheng J; Wang S; Liu P; Xie M; Zhao D
    Virology; 2015 Nov; 485():223-32. PubMed ID: 26298859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common minimal motif for the ligands of HLA-B*27 class I molecules.
    Barriga A; Lorente E; Johnstone C; Mir C; del Val M; López D
    PLoS One; 2014; 9(9):e106772. PubMed ID: 25268942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4-independent upregulation of activation markers in mouse B lymphocytes infected by HRSV.
    Rico MA; Infantes S; Ramos M; Trento A; Johnstone C; Melero JA; Del Val M; López D
    Mol Immunol; 2010 May; 47(9):1802-7. PubMed ID: 20362337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations to predict the availability of peptides with known HLA class I motifs generated by proteolysis of dengue fever virus (DFV) type 1 structural and nonstructural proteins in infected cells.
    Becker Y
    Virus Genes; 1995; 10(3):195-203. PubMed ID: 8560780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.